CD5 CAR-NK-92 cells displayed specific cytotoxic responses against CD5+ cell lines and CD5+ primary tumor cells in vitro and significantly inhibited disease progression in xenograft mouse models (194). This evidence concerns the gene CD5 and neoplasm.